BRIEF—Update on Takeda takeover of Shire

Takeda Pharmaceutical has announced it will hold an extraordinary general meeting of shareholders to vote on its proposed acquisition of Shire on 5 December.

The firm also says that the European regulator will deliver its decision, confirming or withholding approval for the deal, by 20 November.

Takeda has been in discussions with the EU around divesting certain of Shire’s pipeline candidates.